CE Creates, Crescent Enterprises’ venture studio, is the company’s dedicated venture-building arm, focused on building globally competitive ventures from the United Arab Emirates.
Sheraa, Pearl Initiative, and Crescent Enterprises hosted a discussion on startup resilience during market volatility, featuring founders, investors, and ecosystem leaders.
CE-Ventures, the corporate venture capital arm of Crescent Enterprises, today announced its investment in Aptadir Therapeutics in a €40 million seed round supporting the development of the preclinical biotechnology company’s novel class of RNA inhibitor-based therapeutics for genetic disorders.
Crescent Enterprises and MIT Solve renewed the $100,000 Crescent Enterprises AI for Social Innovation Prize for 2027 to support MENA-based innovators addressing global challenges.
Crescent Enterprises partnered with TVS Automobile Solutions to support myTVS’ growth in India, the UAE, and MENA, leading a $45 million Series D funding round.